Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02743858 · ClinicalTrials.gov registry record

Lymphedema Surveillance Study

A clinical trial of Breast Cancer and Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
1,250
Enrollment target
7
Study locations

NCT02743858: Recruiting study of Breast Cancer and Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02743858 is a study of Breast Cancer and Lymphedema that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,250 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02743858, a study of Breast Cancer and Lymphedema, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
1,250 participants
Enrollment target
7
Study locations

Study Summary

This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others don't. Specifically, the investigators want to do tests on the breast tissue that is removed at the time of surgery to see if they can identify inflammation in the breast tissue, which may increase a woman's risk for lymphedema. The investigators will also ask the patient to answer questions to see how much their quality of life is affected by lymphedema, and whether this study can help women by detecting lymphedema earlier.

Primary Outcome

as defined by perometry using rigorous measurement protocols. Bilateral arm measurements will be obtained using the Perometer (Model 350 NT Perometer, Per-System) and the L-Dex U400 (Impedimed, Brisbane, Australia) for bioimpedance measurements.

Conditions Studied

Interventions

  • OTHER Bilateral arm measurements
  • OTHER Body mass index (BMI)
  • BEHAVIORAL Quality of Life Questionnaire
  • OTHER Blood draw

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack (Consent only) - Commack
  • Memorial Sloan Kettering Westchester (Consent only) - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau (Consent only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent only) - Montvale

Trial Details

FieldValue
Enrollment Target 1,250 participants
Start Date 2016-04
Est. Completion 2026-04
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT02743858 shows while recruiting

NCT02743858 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Bilateral arm measurements is the first listed.

NCT02743858 lists 7 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT02743858 about?

NCT02743858 is a clinical study titled "Lymphedema Surveillance Study". This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others don't. Specifically, the investigators want to do tests on the breast tissue that is removed at the...

What is the current status of trial NCT02743858?

This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2016-04. Estimated completion is 2026-04.

What conditions does trial NCT02743858 study?

This clinical trial studies the following conditions: Breast Cancer, Lymphedema.

What interventions are being tested in trial NCT02743858?

The interventions under investigation include: Bilateral arm measurements (OTHER), Body mass index (BMI) (OTHER), Quality of Life Questionnaire (BEHAVIORAL), Blood draw (OTHER).

Who is sponsoring clinical trial NCT02743858?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02743858 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02743858's enrollment target sits among peer trials

1,250 98th of 1224 higher than 1,126 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04670874 · 1,250 participants

    Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

  • NCT04807868 · 1,250 participants

    AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

  • NCT05995821 · 1,250 participants

    Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

  • NCT06024395 · 1,250 participants · NA

    A Stepped Care Approach to Treating Dental Fear

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02743858, the US trial registry maintained by the National Library of Medicine. NCT02743858 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.